perimenopause and semaglutide One of the biggest misconceptions I see in women navigating is that GLP-1 medications are simply “weight loss drugs.” That couldn't be further from the truth, it's time more women Tirzepatide vs Semaglutide for Microdosing

The maximum dose of semaglutide approved for weight management in the U.S

STEP-2 (N=1,210 adults with type 2 diabetes) confirmed that even the 1.0 mg dose of semaglutide produces clinically significant metabolic changes within 8-12 weeks, which is well within the timeframe that ovulatory function may normalize in previously anovulatory women

Its important to recognize that abruptly stopping GLP-1 therapy can lead to common challenges, including weight regain and anxiety about ending treatment

For individuals focused exclusively on type 2 diabetes management, Ozempic may be the preferred option due to its proven efficacy in enhancing glycemic control